Absolutely 100% no question about cash flow funneling into BioTech. I do think IBB is set for a pullback to about $270 which is just another opportunity for long entries. As a matter of fact I see two opportunities to flip before it's heads back over $300 on it way to that $335 number.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.